Physiological barriers to nucleic acid therapeutics and engineering strategies for lipid nanoparticle design, optimization, and clinical translation
revealed that the use of a novel REDOX selective APE1 inhibitor in vitro and in vivo could effectively reduce the progression of bladder cancer, and the combination of this inhibitor with cisplatin, a commonly used chemotherapy drug, was more effective than cisplatin alone [26]
Future research with a larger number of patients, can provide new insights regarding the molecular mechanisms as well as modifiable factors to decrease OS in this clinical entity
Melanoma cell survival in the bloodstream can be attributed to mechanisms that ensure evasion from attack by natural killer (NK)-cells, the most potent mode of host defense against cancers
Among several angiogenesis factors, vascular endothelial growth factor (VEGF) has been the most thoroughly studied
In UK practice, monitoring is primarily based on clinical response rather than routine blood tests, as post-treatment serum B12 measurements can be misleadingly high and may not reflect tissue levels
